Published in Value Health on January 01, 2011
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease. Circulation (2014) 1.44
Lung cancer screening with low-dose computed tomography for primary care providers. Prim Care (2014) 0.90
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada. J Thorac Oncol (2014) 0.81
CD24+/CD38- as new prognostic marker for non-small cell lung cancer. Multidiscip Respir Med (2013) 0.79
Estimating the lifelong health impact and financial burdens of different types of lung cancer. BMC Cancer (2013) 0.79
Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers. BMC Health Serv Res (2014) 0.79
Economic Benefits and Treatment Progress as Determinants of the Sustainability of Vietnamese Voluntary Co-Located Patients Clusters. J Public Health Res (2017) 0.78
Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy. BMJ Open (2015) 0.76
Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer. Oncologist (2015) 0.76
The attributable annual health costs of U.S. occupational lead poisoning. Int J Occup Environ Health (2016) 0.75
Continuous Activity Monitoring During Concurrent Chemoradiotherapy. Int J Radiat Oncol Biol Phys (2016) 0.75
Medical costs and quality-adjusted life years associated with smoking: a systematic review. BMC Public Health (2016) 0.75
Personal financial effects of multiple myeloma and its treatment. Cancer Nurs (2013) 0.75
Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents. Clinicoecon Outcomes Res (2013) 0.75
A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. Clinicoecon Outcomes Res (2017) 0.75
Minimally invasive vs open nephrectomy in the modern era: does approach matter? World J Urol (2017) 0.75
Use of and spending on supportive care medications among Medicare beneficiaries with cancer. Support Care Cancer (2014) 0.75
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
Racial differences in the treatment of early-stage lung cancer. N Engl J Med (1999) 9.65
Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst (2008) 7.85
Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol (2004) 7.45
Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care (2002) 4.88
Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst (2008) 4.53
Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst (1995) 3.81
Medicare beneficiaries' costs of care in the last year of life. Health Aff (Millwood) (2001) 3.56
Cost of cancer care: issues and implications. J Clin Oncol (2007) 3.00
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol (2001) 2.73
Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. JAMA (2001) 2.55
Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care (1995) 2.55
Influence of age on Medicare expenditures and medical care in the last year of life. JAMA (2001) 2.53
Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries. Health Serv Res (1999) 2.49
Who gets chemotherapy for metastatic lung cancer? Chest (2000) 2.27
The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol (2005) 2.21
Estimating the cost of informal caregiving for elderly patients with cancer. J Clin Oncol (2001) 1.92
Out-of-pocket health-care expenditures among older Americans with cancer. Value Health (2004) 1.86
Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst (2008) 1.83
Cost of care for cancer in a health maintenance organization. Health Care Financ Rev (1997) 1.81
Estimating the treatment costs of breast and lung cancer. Med Care (1991) 1.80
Trends in end-of-life ICU use among older adults with advanced lung cancer. Chest (2007) 1.76
Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol (2004) 1.55
Costs of cancer care in the USA: a descriptive review. Nat Clin Pract Oncol (2007) 1.54
Assistance from family members, friends, paid care givers, and volunteers in the care of terminally ill patients. N Engl J Med (1999) 1.44
Significant progress in palliative treatment of non-small cell lung cancer in the past decade. Chest (2005) 1.43
How important are out-of-pocket costs to rural patients' cancer care decisions? Can J Rural Med (2009) 1.23
Measuring costs: administrative claims data, clinical trials, and beyond. Med Care (2002) 1.16
Health care costing: data, methods, current applications. Med Care (2009) 1.13
Ethnic/racial disparities in hospital procedure volume for lung resection for lung cancer. Med Care (2007) 1.12
Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg (2007) 1.05
The value of medical interventions for lung cancer in the elderly: results from SEER-CMHSF. Cancer (2007) 1.04
Trends in out-of-pocket healthcare costs among older community-dwelling Medicare beneficiaries. Am J Manag Care (2008) 0.90
Value and increased cost sharing in the American health care system. Health Serv Res (2008) 0.90
Adjuvant treatment of lung cancer: current status and potential applications of new regimens. Lung Cancer (2004) 0.87
How much 'skin in the game' do medicare beneficiaries have? The increasing financial burden of health care spending, 1997-2003. Health Aff (Millwood) (2007) 0.87
Rising out-of-pocket costs in disease management programs. Am J Manag Care (2006) 0.87
Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer. Cancer (2008) 0.80
Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol (2004) 7.45
Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med (2009) 6.46
Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA (2010) 5.78
Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol (2008) 5.61
Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology (2003) 5.42
Under use of necessary care among cancer survivors. Cancer (2004) 5.31
Characterization of human atherosclerosis by optical coherence tomography. Circulation (2002) 5.04
Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med (2012) 4.72
Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation (2003) 4.69
Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol (2009) 4.39
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA (2004) 4.36
Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) (2006) 4.33
Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ (2004) 4.13
A rational approach to the stool ova and parasite examination. Clin Infect Dis (2006) 4.06
Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst (2006) 4.01
Physician factors associated with discussions about end-of-life care. Cancer (2010) 3.54
Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulation. J Clin Oncol (2011) 3.53
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. J Clin Oncol (2012) 3.36
Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2006) 3.28
How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff (Millwood) (2010) 3.24
In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation (2005) 3.23
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst (2006) 3.19
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg (2003) 3.13
Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis. Ann Intern Med (2013) 2.96
Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.77
Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care (2005) 2.75
Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging (2012) 2.72
Paraesophageal hernias: operation or observation? Ann Surg (2002) 2.71
Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol (2008) 2.68
Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med (2008) 2.64
Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst (2004) 2.53
Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer. J Clin Oncol (2011) 2.52
Utilization of diagnostic medical imaging: comparison of radiologist referral versus same-specialty referral. Radiology (2007) 2.48
Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. JAMA (2012) 2.47
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37
Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med (2009) 2.36
Application of recently developed computer algorithm for automatic classification of unstructured radiology reports: validation study. Radiology (2004) 2.36
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst (2006) 2.34
Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study. Ann Intern Med (2011) 2.34
Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol (2011) 2.31
Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst (2012) 2.30
Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer (2003) 2.26
Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol (2009) 2.26
Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg (2006) 2.25
The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr (2010) 2.25
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer (2003) 2.22
The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol (2005) 2.21
Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology (2012) 2.14
Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression. Eur Heart J (2006) 2.13
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Noninvasive assessment of murine pulmonary arterial pressure: validation and application to models of pulmonary hypertension. Circ Cardiovasc Imaging (2009) 2.05
Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J Neurosci (2003) 2.05
Measuring complications of cancer treatment using the SEER-Medicare data. Med Care (2002) 2.05
Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol (2004) 2.03
End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector. Cancer (2010) 2.01
Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med (2013) 2.00
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol (2012) 2.00
Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J (2006) 1.98
CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology (2002) 1.98
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
Consensus interpretation in imaging research: is there a better way? Radiology (2010) 1.94
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol (2011) 1.93
Accelerated partial breast irradiation using brachytherapy for breast cancer: patterns in utilization and guideline concordance. J Natl Cancer Inst (2011) 1.92
Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology (2005) 1.91
The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med (2002) 1.90
CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure. AJR Am J Roentgenol (2006) 1.89
Persistent and reversible cardiac dysfunction among amateur marathon runners. Eur Heart J (2006) 1.88
Diffusion tensor MRI of myocardial fibers and sheets: correspondence with visible cut-face texture. J Magn Reson Imaging (2003) 1.88
CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology (2002) 1.85
Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine. Gastrointest Endosc (2009) 1.79
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol (2006) 1.75
Racial and ethnic differences in end-of-life care in fee-for-service Medicare beneficiaries with advanced cancer. J Am Geriatr Soc (2008) 1.74
Automated computer-assisted categorization of radiology reports. AJR Am J Roentgenol (2005) 1.74
Breast cancer survivors' perceptions of survivorship care options. J Clin Oncol (2011) 1.72
Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol (2008) 1.70
Attenuation of acute and chronic pulmonary emboli. Radiology (2005) 1.69
Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol (2009) 1.68
The status of appendiceal CT in an urban medical center 5 years after its introduction: experience with 753 patients. AJR Am J Roentgenol (2005) 1.66
Mammographic screening: patterns of use and estimated impact on breast carcinoma survival. Cancer (2004) 1.66
The effect on survival of continuing chemotherapy to near death. BMC Palliat Care (2011) 1.66
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer. J Clin Oncol (2006) 1.64
Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer? J Thorac Oncol (2006) 1.64
Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology (2013) 1.63